Literature DB >> 708016

Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.

J Wüst, T D Wilkins.   

Abstract

The minimal inhibitory concentrations (MICs) of sulfamethoxazole and trimethoprim against 144 strains of obligately anaerobic bacteria were determined on Diagnostic Sensitivity Test agar (Oxoid) or in prereduced Diagnostic Sensitivity Test broth, both supplemented with sodium pyruvate (1 mg/ml), hemin (5 mug/ml), and vitamin K(1) (1 mug/ml). Fifty-eight percent of the strains were susceptible to sulfamethoxazole alone (MIC </= 16 mug/ml), only 12% were susceptible to trimethoprim alone (MIC </= 1 mug/ml), and 85% were susceptible to the combination of sulfamethoxazole plus trimethoprim (MIC </= 16 mug/ml) at a ratio of 19:1. All 45 strains of the Bacteroides fragilis group were susceptible to the combination. Synergy of the combination was often observed by a checkerboard MIC determination of 123 strains, usually most markedly when the ratio of the two components was near 1:1. However, there was also synergism at the ratio of sulfamethoxazole to trimethoprim of 16:1 in 61 (53.5%) of the 114 strains that could be evaluated for synergistic activity. When the strains were tested by the broth-disk test proposed by Wilkins and Thiel, modified by using prereduced Diagnostic Sensitivity Test broth instead of brain heart infusion broth and by using a smaller inoculum, there was over 90% correlation with the MICs. Poor results were found when the broth-disk tests were performed in brain heart infusion broth. There was very poor correlation between inhibition zone diameters by an agar diffusion method and MICs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708016      PMCID: PMC352469          DOI: 10.1128/AAC.14.3.384

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

Authors:  R Ferone; S R Bushby; J J Burchall; W D Moore; D Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

3.  Medium for use in antibiotic susceptibility testing of anaerobic bacteria.

Authors:  T D Wilkins; S Chalgren
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

4.  [Bacteroides fragilis septicemia. Incidence and sensitivity of the strains to antibiotics].

Authors:  E Schoutens; M Labbé; E Yourassowsky
Journal:  Pathol Biol (Paris)       Date:  1973-04

5.  The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin.

Authors:  V L Sutter; S M Finegold
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

6.  Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.

Authors:  E Yourassowsky; M P Vanderlinden; E Schoutens
Journal:  J Clin Pathol       Date:  1974-11       Impact factor: 3.411

7.  Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole.

Authors:  O A Okubadejo
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

8.  Bacteroides in the blood.

Authors:  O A Okubadejo; P J Green; D J Payne
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

9.  Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria.

Authors:  T D Wilkins; T Thiel
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

10.  Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

View more
  14 in total

1.  Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  Therapy of anaerobic infections.

Authors:  T D Wilkins; S E West
Journal:  Infection       Date:  1983       Impact factor: 3.553

3.  Activity of brodimoprim and metioprim alone and in combination with sulfonamides against anaerobic bacteria.

Authors:  J Wüst; J Schwarzenbach
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

4.  Agar dilution susceptibility of Bacteroides spp. to sulfamethoxazole and trimethoprim: correlation with a disk diffusion technique.

Authors:  T V Riley
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

5.  Microbiological perspectives of co-trimoxazole.

Authors:  A Bauernfeind; G Hörl; B Przyklenk
Journal:  Infection       Date:  1987       Impact factor: 3.553

6.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

7.  [Antibiotic resistance of anaerobic bacteria (author's transl)].

Authors:  W Niederau; U Höffler; G Pulverer
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 8.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

9.  Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.

Authors:  J M Swenson; C Thornsberry; L M McCroskey; C L Hatheway; V R Dowell
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Occurrence and Dissipation of the Antibiotics Sulfamethoxazole, Sulfadiazine, Trimethoprim, and Enrofloxacin in the Mekong Delta, Vietnam.

Authors:  Chau Nguyen Dang Giang; Zita Sebesvari; Fabrice Renaud; Ingrid Rosendahl; Quang Hoang Minh; Wulf Amelung
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.